Arcadia Biosciences (RKDA) to Present at H.C. Wainwright's 22nd Annual Global Investment Conference September 14-16, 2020
DAVIS, Calif., Sept. 9, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that it will be featured as a presenting company at the 22nd Annual Global Investment Conference sponsored by H.C Wainwright. The conference is being held virtually on September 14-16, 2020. Matthew Plavan, Arcadia's president and CEO will present a business overview at 2:00 p.m. EDT on Wednesday, September 16, 2020 and will be available for one-on-one web meetings with investors. Institutional investors may request a meeting by registering for the conference at www.hccwevents.com. The presentation will be webcast live here, and a replay will be available in the Investors section of the company's website. About Arcadia Biosciences LinkedIn: Arcadia Biosciences Twitter: @ArcadiaAg View original content to download multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-to-present-at-hc-wainwrights-22nd-annual-global-investment-conference-september-14-16-2020-301126240.html SOURCE Arcadia Biosciences, Inc. |
||
Company Codes: NASDAQ-SMALL:RKDA |